期刊
JOURNAL OF MEDICAL GENETICS
卷 54, 期 4, 页码 260-268出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2016-104215
关键词
-
资金
- WIMM Strategic Alliance [G0902418, MC_UU_12025]
- National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (JCT and AOMW)
- Department of Health, UK, Quality, Improvement, Development and Initiative Scheme (QIDIS) (AOMW)
- Wellcome Trust [093329]
- Senior Investigator Award [102731]
Background Craniosynostosis, the premature fusion of one or more cranial sutures, occurs in similar to 1 in 2250 births, either in isolation or as part of a syndrome. Mutations in at least 57 genes have been associated with craniosynostosis, but only a minority of these are included in routine laboratory genetic testing. Methods We used exome or whole genome sequencing to seek a genetic cause in a cohort of 40 subjects with craniosynostosis, selected by clinical or molecular geneticists as being high-priority cases, and in whom prior clinically driven genetic testing had been negative. Results We identified likely associated mutations in 15 patients (37.5%), involving 14 different genes. All genes were mutated in single families, except for IL11RA (two families). We classified the other positive diagnoses as follows: commonly mutated craniosynostosis genes with atypical presentation (EFNB1, TWIST1); other core craniosynostosis genes (CDC45, MSX2, ZIC1); genes for which mutations are only rarely associated with craniosynostosis (FBN1, HUWE1, KRAS, STAT3); and known disease genes for which a causal relationship with craniosynostosis is currently unknown (AHDC1, NTRK2). In two further families, likely novel disease genes are currently undergoing functional validation. In 5 of the 15 positive cases, the (previously unanticipated) molecular diagnosis had immediate, actionable consequences for either genetic or medical management (mutations in EFNB1, FBN1, KRAS, NTRK2, STAT3). Conclusions This substantial genetic heterogeneity, and the multiple actionable mutations identified, emphasises the benefits of exome/whole genome sequencing to identify causal mutations in craniosynostosis cases for which routine clinical testing has yielded negative results.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据